ZNTL Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress

a month ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

2 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

4 months ago - By: The Motley Fool

Zentalis (ZNTL) Q2 Loss Narrows 70%

2 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

4 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary

5 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

7 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress

7 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

8 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

8 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

9 months ago - By: Benzinga - Mentions: APDN PRPH IBO SILO ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

9 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates

9 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025

9 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

9 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL

10 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL

10 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL

10 months ago - By: Benzinga - Mentions: NBY AZTR OGEN XNCR ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

10 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL

10 months ago - By: ZENTALIS PHARMACEUTICALS

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

10 months ago - By: ZENTALIS PHARMACEUTICALS